Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2005 Apr 14;89(5):968–978. doi: 10.1016/0091-6749(92)90219-R

Rhinovirus 39 infection in allergic and nonallergic subjects☆

William J Doyle ∗,†, David P Skoner ∗∗, Philip Fireman ∗∗, James T Seroky ∗, Israel Green ∗, Frederick Ruben ∗∗∗, David R Kardatzke ∗∗∗∗, Jack M Gwaltney ∗∗∗∗∗
PMCID: PMC7133183  PMID: 1316390

Abstract

To determine if individuals with allergic rhinitis are hyperresponsive to upper respiratory tract viral infections, 20 allergic and 18 nonallergic, susceptible, adult volunteers were challenged and infected with rhinovirus type 39 before the pollen seasons. Before challenge and on each of 6 days of cloister, all volunteers were interviewed for symptoms and completed a test battery consisting of evaluations of secretion production by weighed tissues, nasal patency by active posterior rhinomanometry, nasal clearance by the dyed saccharin technique, pulmonary function by spirometry, eustachian tube function by sonotubometry, and middle ear status by tympanometry. The symptomatology and pathophysiology resulting from the rhinovirus infection were consistent with those reported in previous studies with this challenge system. Between-group comparisons revealed no differences in symptom presentation, nasal secretion production, or overall pathophysiologic response. However, for decreased mucociliary clearance rate, increased nasal congestion, eustachian tube dysfunction, and symptoms of sneezing, the allergic group demonstrated an earlier onset compared with that of the nonallergic group. The biologic significance of the differences in onset of dysfunction is tempered by the observation that the temporal pattern of responses in the allergic group was similar with that of nonallergic subjects in previous studies. The results of the present study do not support the hypothesis of a physiologic hyperresponsiveness to rhinovirus type 39 infection in allergic subjects during nonallergy seasons.

Keywords: Rhinovirus, allergy, eustachian tube, URI, nasal work

Abbreviations: Allergic rhinitis URI, Upper respiratory infection; RV-39, Rhinovirus type 39; CHP, Children's Hospital of Pittsburgh; FAST, Fluoroallergosorbent test; ANOVA, Analysis of variance; SPT, Skin prick test; ET, Eustachian tube

Footnotes

☆

Supported in part by National Institutes of Health Grant AI 19262, and General Clinical Research Centers Grant MO/RR 000 84.

References

  • 1.van Wijk R.G., Dieges P.H. Comparison of nasal responsiveness to histamine, methacholine and phenolamine in allergic rhinitis patients and controls. Clin Allergy. 1987;17:563–770. doi: 10.1111/j.1365-2222.1987.tb02052.x. [DOI] [PubMed] [Google Scholar]
  • 2.Asakura K., Enomoto K., Ara H., Azuma E., Kataura A. Nasal responsiveness to methacholine stimulation in allergic rhinitis patients. Arch Otorhinolaryngol. 1984;239:273–278. doi: 10.1007/BF00464255. [DOI] [PubMed] [Google Scholar]
  • 3.Okuda M., Ohtuska H., Sakaguchi K., Watase T. Nasal histamine sensitivity in allergic rhinitis. Ann Allergy. 1983;51:51–55. [PubMed] [Google Scholar]
  • 4.Doyle W.J., Boehm S., Skoner D.P. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. Allergy Clin Immunol. 1990;86:924–935. doi: 10.1016/s0091-6749(05)80156-3. [DOI] [PubMed] [Google Scholar]
  • 5.Doyle W.J., McBride T.P., Skoner D.P., Maddern B.I.Z., Gwaltney J.M., Uhrin M. A double-blind placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge. J Pediatr Inf Dis. 1988;7:229–238. doi: 10.1097/00006454-198803000-00033. [DOI] [PubMed] [Google Scholar]
  • 6.Sperber S. Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM. Beneficial effects of naprasen in experimental colds [submitted]. J Infect Dis.
  • 7.Naclerio R.M., Proud D., Lichtenstein L.M. Kinins are generated during experimental rhinovirus cold. J Infect Dis. 1988;157:133–142. doi: 10.1093/infdis/157.1.133. [DOI] [PubMed] [Google Scholar]
  • 8.Turner R.B., Hendley J.O., Gwaltney J.M. Shedding of infected ciliated epithelial cells in rhinovirus colds. J Infect Dis. 1982;145:849–853. doi: 10.1093/infdis/145.6.849. [DOI] [PubMed] [Google Scholar]
  • 9.Kaliner M. The cholinergic nervous system and immediate hypersensitivity. I. Eccrine sweat responses in allergic patients. J Allergy Clin Immunol. 1976;58:308–315. doi: 10.1016/0091-6749(76)90136-6. [DOI] [PubMed] [Google Scholar]
  • 10.Smith L.J., Shelhamer J.H., Kaliner M. Cholinergic nervous system and immediate hypersensitivity. II. An analysis of pupillary responses. J Allergy Clin Immunol. 1980;66:374–378. doi: 10.1016/0091-6749(80)90116-5. [DOI] [PubMed] [Google Scholar]
  • 11.Jackson R.T., Teichgraeber J. Low-dose topical atropine for rhinorrhea. Arch Otolaryngol. 1981;107:288–289. doi: 10.1001/archotol.1981.00790410026006. [DOI] [PubMed] [Google Scholar]
  • 12.Gaffey M.J., Gwaltney J.M., Dressler W.E., Sorrentino J.V., Hayden F.G. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds. Am Rev Respir Dis. 1987;135:241–244. doi: 10.1164/arrd.1987.135.1.241. [DOI] [PubMed] [Google Scholar]
  • 13.Gaffey M.J., Hayden F.G., Boyd J.C., Gwaltney J.M. Tipratropium bromide treatment of experimental rhinovirus infection. Antimicrob Agents Chemother. 1988;32:1644–1647. doi: 10.1128/aac.32.11.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Callow K.A., Tyrrell D.A.J., Shaw R.J., Fitzharris P., Wardiaw A.J., Kay A.B. Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteers. Clin Allergy. 1988;18:119–129. doi: 10.1111/j.1365-2222.1988.tb02851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Katz D.H. Regulation of the 1gE system: experimental and clinical aspects. Allergy. 1984;39:81–106. doi: 10.1111/j.1398-9995.1984.tb01940.x. [DOI] [PubMed] [Google Scholar]
  • 16.Leung D.Y.M., Geha R.S. Regulation of IgE synthesis in man. Clin Immunol Rev. 1984;3:1–24. [PubMed] [Google Scholar]
  • 17.Hendey M. An introduction to allergic disease. JR Coll Physicians Lond. 1985;19:147–153. [PMC free article] [PubMed] [Google Scholar]
  • 18.Pelikan Z., Plikan-Filipek M. Role of nasal allergy in chronic maxillary sinusitis—diagnostic value of nasal challenge with allergen. J Allergy Clin Immunol. 1990;86:484–491. doi: 10.1016/s0091-6749(05)80203-9. [DOI] [PubMed] [Google Scholar]
  • 19.Bernstein J.M., Lee J., Conboy K., Ellis E., Li P. The role of IgE mediated hypersensitivity in recurrent otitis media with effusion. Am J Otol. 1983;5:66–69. [PubMed] [Google Scholar]
  • 20.Lemanske R.F., Dick E.C., Swenson C.A., Vrtis R.F., Busse W.W. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest. 1989;83:1–10. doi: 10.1172/JCI113843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Gwaltney J.M., Jordan W. Rhinovirus and respiratory illness in university students. Am Rev Respir Dis. 1966;93:362–371. [Google Scholar]
  • 22.Doyle W.J., McBride T.P., Swarts J.D., Hayden F.G., Gwaltney J.M. The response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge. Am J Rhinol. 1988;2:149–154. doi: 10.1097/00006454-198803000-00033. [DOI] [PubMed] [Google Scholar]
  • 23.McBride T.P., Doyle W.J., Hayden F.G., Gwaltney J.M. Alteration of eustachian tube function, middle ear pressure and nasal patency in response to an experimental rhinovirus challenge. Arch Otol. 1989;115:1054–1059. doi: 10.1001/archotol.1989.01860330044014. [DOI] [PubMed] [Google Scholar]
  • 24.Hayden F.G., Gwaltney J.M. Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. Antimicrob Agents Chemother. 1982;21:892–897. doi: 10.1128/aac.21.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hsia J., Goldstein A.L., Simon G.L., Sztein M., Hayden F.G. Peripheral blood mononuclear cell interleukin-2 and interferon production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infection. J Infect Dis. 1990;162:591–597. doi: 10.1093/infdis/162.3.591. [DOI] [PubMed] [Google Scholar]
  • 26.Connel J.T. Quantitative intranasal pollen challenge. III. The priming effect. J Allergy. 1969;43:33–44. doi: 10.1016/0021-8707(69)90018-5. [DOI] [PubMed] [Google Scholar]
  • 27.Skoner D.P., Doyle W.J., Boehm S., Fireman P. Priming of the nose and eustachian tube to intranasal challenge. Am J Rhinol. 1989;3:53–57. [Google Scholar]
  • 28.van Wijk R.G., Dieges P.H., van Toorenenbergen A.W. Seasonal variability in nasal sensitivity to house dust mite extract. Rhinology. 1987;225:41–48. [PubMed] [Google Scholar]

Articles from The Journal of Allergy and Clinical Immunology are provided here courtesy of Elsevier

RESOURCES